ArticleOxidative medicine and cellular longevity2023

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke.

Yuanyuan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.